The (Ir)relevance of Group Size in Health Care Priority Setting: A Reply to Juth

  title={The (Ir)relevance of Group Size in Health Care Priority Setting: A Reply to Juth},
  author={Lars Sandman and Erik Gustavsson},
  booktitle={Health Care Analysis},
How to handle orphan drugs for rare diseases is a pressing problem in current health-care. Due to the group size of patients affecting the cost of treatment, they risk being disadvantaged in relation to existing cost-effectiveness thresholds. In an article by Niklas Juth it has been argued that it is irrelevant to take indirectly operative factors like group size into account since such a compensation would risk discounting the use of cost, a relevant factor, altogether. In this article we… CONTINUE READING
This paper has been referenced on Twitter 3 times. VIEW TWEETS

From This Paper

Topics from this paper.


Publications referenced by this paper.

Prioritering av läkemedel för behandling av patienter med sällsynta tillstånd

  • P. Carlsson, M. Hoffman, Levin, L.-Å, L. Sandman, J. Wiss
  • Reviderad version. Prioriteringscentrums…
  • 2015
3 Excerpts

Open and fair—Priority setting in the health service. (Åpent og rettferdig— prioriteringer i helsetjenesten)

  • O. N. Reports
  • 2014

Multikriterieanalyser vid prioriteringar inom hälso-och sjukvården—Kriterier och analysmetoder

  • E. Gustavsson, J. Wiss
  • Prioriteringscentrums rapportserie (vol. :2…
  • 2013
2 Excerpts

Similar Papers

Loading similar papers…